版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
1、食管癌組織中Survivin和Ki67的表達及臨床意義 作者:李秀娟 范 婕 李玉珍 王淑強【摘要】 目的:觀察Survivin和Ki67在食管鱗癌中的表達,并探討Survivin與Ki67的表達關系及其臨床意義。方法:應用免疫組織化學法檢測70例食管鱗癌組織石蠟切片Survivin和Ki67的表達,分析Survivin表達與臨床病理因素及Ki67的關系。結果:Survivin在食管鱗癌組織中的表達率為72.9%(51/70),Ki67在食管鱗癌組織中的表達率為67.1%(47/70)。Survivin表達和Ki67表達與食管鱗癌分化程度、淋巴結轉移、TNM分期明顯相關(P<0.
2、05)。Survivin表達和Ki67表達呈正相關(P<0.05)。結論:Survivin和Ki67可作為判斷食管癌組織惡性程度和預后的指標之一。 【關鍵詞】 食管;鱗狀細胞/腫瘤;Survivin;Ki67Esophageal carcinoma is one of the most frequently malignant tumors in China.A method for identifying cancer cell proliferation and spreading is important to commence the effective treatmen
3、t and to improve survival for ESCC patients.The process of esophageal tumorigenesis at the molecular level is related to disorders of cell amplification,differentiation,senescence and apoptosis.The genetic bases underlying esophageal tumorigenesis have been partly understood in the past few years,in
4、cluding a loss of the anti2 / 20oncogene p53 and overexpression of epidermal growth factor receptor or cMyc1.However,other molecular mechanisms involved in esophageal tumorigenesis progress are still widely unknown.Survivin is a kind of protein that is highly expressed in a vast number of malignanci
5、es,but is minimally expressed in normal tissues.It plays a role as an inhibitor of cell death in cancer cells,thus facilitating the growth of these cells2.Ki67 is a marker of cell growth.This muclear antigen is expressed during all phases of the cell cycle(G1,S,G2 and mitosis),except phase G0.In rec
6、ent studies,important correlation was found between ki67 and the growth,invision,metastasis and prognosis3.In this study,the effects of Survivin and Ki67 in the formation and progression of ESCC were investigated,and the expression of them in ESCC was detected.1 MATERIALS AND METHODS1.1 Clinical Dat
7、a70 cases with ESCC were selected from the First Affiliated Hospital of Hebei North University from January 2000 to June 2005.There were 23 male and 47 female.The patients were given preoperative examination including biopsy for diagnosis,barium Xray and CT,and no treatment was given before operatio
8、n.Radical resection was performed in each patient,and all the samples underwent postoperative pathological examination.There were 40 cases with stage and 30 cases with stage cancer according to the American Joint Committee on Cancer staging manual(AJCC,2002)4.With regard to postoperative histologica
9、l results,33 were welldifferentiated and 37 poorly differentiated.And 10 cases normal esophagus tissues were used as negative control.1.2 ImmunohistochemistryA paraffin section of the ESCC sample was deparaffinized and rehydrated in graded alcohol to water.Antigenic enhancement was performed by subm
10、erging in citrate buffer(pH6.0)and microwaving.Endogenous peroxide activity was quenched by applying 0.3% hydrogen peroxide for 10 min.The primary antibodies such as rabbit polyclonal antihuman Survivin and rat monoclonal antihuman Ki67(both from Beijing Zhongshan Golden Bridge Biotechnology Ltd)wer
11、e incubated for 60 min at 37.After washing,the tissue sections were incubated in the second antibodies for 30 min at 37.The reaction products were visualized by 3,3diaminobenzidine tetrahydrochloride(DAB).Slides were then counterstained with hematoxylin,dehydrated through alcohol of increasing conce
12、ntration,placed in xylene,coverslipped using Permount,and analyzed under light microscopy.The positive Survivin and Ki67 were stained brown yellow,the former was localized in the cytoplasm of the cells and the later in the nucleus.The percentage of positive tumor cells was recorded as follows:negati
13、ve(5% of tumor cells positive),positive(>5% of tumor cells positive)5.1.3 Statistical analysisData analysis was carried out using SPSS statistical software package and verified with 2test and spearman,s rank.The value with P<0.05 was considered statistically significant.2 RESULTS2.1 Th
14、e expression of Survivin in ESCCAs determined by IHC,51(72.9%)of 70 cases was positive for in ESCC.In 10 cases of normal esophageal mucosal samples,Survivin did not express.The relationship between expression and clinicopathological variables was examined between the positive and negative groups.No
15、statistical difference between two groups was found with respect to gender(P>0.05).However,Survivin expression was correlated to cell differentiation,lymph node metastasis and tumor stage(P<0.05).Survivin protein was highly expressed in ESCC(Table 1).Table 1 The expression of Survivin
16、or Ki67 in ESCCclinicalnSurvivin expressionpositive2 valueP valueKi67 expressionpositive2 valueP valueSex male2317 female47340.019>0.0517300.712>0.05Tissue differentiation well3319 low37327.37<0.0518294.49<0.05Lymph node Metastasis negative2614 positive44377.56<0.0
17、513345.51<0.05TNM Stage 、4025 、30265.06<0.0522256.23<0.052.2 The expression of Ki67 in ESCCAs table 1 shows,the expression of Ki67 was significantly higher in poorly differentiated,lymphnode metastasis and stage group.2.3 The relationship between Survivin and Ki67 in ESCCAfter s
18、pearmans rank correlation analysis,it could be found that in ESCC the expression of Ki67 was correlated with Survivin(r=0.37,P<0.05).Table 2 The relationship between Survivin and Ki67 in ESCC(n)SurvivinKi67+-Total+35 1651-14519Total4921703 DISCUSSIONRegulation of apoptosis is critical for nor
19、mal embryonic development and for homeostasis in adult tissues.Cancellation of this process with increased resistance to cell death is a common feature of malignant cells and represents a significant obstacle to therapy of human cancers6.Apoptosis resistance in ESCC accounts for its poor response to
20、 chemotherapy and enhanced metastasis7.Inhibitor of apoptosis(IAP)has been proved to be crucial regulators of the molecular mechanisms of apoptosis.Among the IAP members,Survivin is unique in which it is involved in both control of cell division and inhibition of apoptpsis8.It is expressed during fe
21、tal development,but not in nonproliferating adult tissuess.Survivin is also overexpressed in most human cancers,including ESCC.In ESCC,overexpression of Survivin has been demonstrated by many groups.Survivin expression has been reported to correlate with the proliferative activity of cancer cells9,o
22、verall survival of patients10,the response of patients to chemotherapy11 and recently the apoptotic cell ratio in esophageal cancer12.Survivin inhibits apoptosis in cells exposed to diverse apoptotic stimuli by associating with microtubules of the mitotic spindles and inhibiting caspase3 and caspase
23、7 activity.Overexpression of survivin has oncogenic potential because it may overcome the G2/M phase checkpoint to enforce progression of cells through mitosis.The vast majority of cancers express survivin protein,suggesting that reactivation of survivin gene expression occurs commonly in cancers.Co
24、rrespondingly,previous reports have shown that the presence of survivin is associated with poor survival among patients with colorectal cancer,non smallcell lung cancer,breast cancer and neuroblastoma.In the study on 70 patients with ESCC,it was showed that Survivin protein was expressed in 72.9%(51
25、/70)of these tumours.The positive rate of Survivin in the well differentitation was 57.6%(19/33),while it was 86.5%(32/37)in the low differentitation,the comparison between the two groups had a significant difference(P<0.05).Correspondingly,the expression of Survivin was significantly associa
26、ted with lymph mode metastasis and TNM stage of ESCC(P<0.05),while less associated with gender(P>0.05).This means that Survivin plays a vital role in the occurrence process of ESCC.Several studies on ESCC have indicated that there is a relationship between survivin expression and the u
27、ltimate behavior of the carcinoma.Since the expression pattern of survivin is selective to cancer cells,it has been described as an “ideal target” for cancer therapy.Currently,several preclinical and clinical trials are ongoing to investigate the effects of interfering with survivin function in canc
28、er cells as a biologic therapy.Ki67 is a maker of cell growth.This nuclear antigen is expressed during all phases of the cell cycle(G1,S,G2 and mitosis),except phase G0 and,in several studies,cells in the growth phase appear to be more radiosensitive than quiescent cells,particularly in esophageal s
29、quamous cell cancer.Research showed that overexpression of Ki67 was a independent factor for complete endoscopic response after chemoradiotherapy for esophageal cancer13.In this research,the expression of Ki67 was significantly associated with tissue differentitation,lymph mode metastasis and TNM st
30、age of ESCC(P<0.05),while less associated with gender(P>0.05).In the present study,significant correlation was found between Survivin and Ki67 expression with histological differentiation grade,lymphnode metastasis,TNM stage of ESCC(P<0.05).Survivin expression was significantly
31、correlated with Ki67 expression(r=0.37,P<0.05).So the expression of Survivin protein might promote cell proliferation of esophageal cancer.In the case of ESCC,Survivin is a potentially significant protein in the diagnosis,prognosis and treatment of ESCC.Survivin and Ki67 are overexpressed in
32、tumor cells and play role in the carcinogenesis process,further prospective studies are necessary to investigate the impact of these prognostic factors.【參考文獻】 1 Kuwano H,Kato H,Miyazaki T,et al.Genetic alterations in esophageal cancerJ.Surg Today,2005,35:7182 Wang TT,Qian XP,Liu BR.Survivin:Potentia
33、l role in diagnosis,prognosis and targeted therapy of gastric cancerJ.World J Gastroenterol,2007,13(20):278427903 Gzyzewska J,GuzinskaUstymowicz K,Lebelt A,et al.Evaluation of proliferating markers Ki67,PCNA in gastric cancersJ.Rocz Akad Med Bialymst,2004,49(1):64664 Greene FL.American Joint Committee on Cancer,American Cancer Society.AJCC cancer staging manuaM.6th ed.New York:Springer,2002.91985 Kuang LP,Wu MY.Expression and clinical significance of MGMT and survivin in esophageal carcinomaJ.Cancer Res Preven Treat,2007,34(1):12146 Schmitt CA.Senescence,apoptosis and th
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權益所有人同意不得將文件中的內容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- NX-1607-GMP-Cbl-b-IN-3-GMP-生命科學試劑-MCE-7412
- Isoorotidine-生命科學試劑-MCE-5873
- 3-Methoxy-prostaglandin-F1α-生命科學試劑-MCE-1002
- 二零二五年度紅木家具品牌授權合同及清單
- 二零二五年度父母無償贈與子女房產(chǎn)并約定維修責任協(xié)議
- 二零二五年度新能源儲能技術融資合同
- 施工現(xiàn)場施工防突發(fā)公共衛(wèi)生事件制度
- 施工單位關于協(xié)調配合的聯(lián)絡函
- 雨雪天氣的應急預案
- 《運營管理 第7版》課件-chapt.05-選址與設施布置
- 2025保安部年度工作計劃
- 2024年江蘇經(jīng)貿(mào)職業(yè)技術學院單招職業(yè)適應性測試題庫
- 人居環(huán)境綜合治理項目項目背景及必要性分析
- 招標采購基礎知識培訓
- 2024年廣東省公務員錄用考試《行測》試題及答案解析
- 電力系統(tǒng)分布式模型預測控制方法綜述與展望
- 2024年注冊建筑師-二級注冊建筑師考試近5年真題附答案
- 2024年貴州省中考理科綜合試卷(含答案)
- 無人機技術與遙感
- 燃煤電廠超低排放煙氣治理工程技術規(guī)范(HJ 2053-2018)
- TSG-T7001-2023電梯監(jiān)督檢驗和定期檢驗規(guī)則宣貫解讀
評論
0/150
提交評論